Sir Shadi Lal Enterprises Ltd

The company’s capital structure is highly leveraged, with total liabilities of ₹5,252.66 million and total equity of -₹2,096.15 million, resulting in a debt-to-equity ratio of -1.58. Liquidity is constrained, as reflected in a current ratio of 0.63, indicating that current assets are insufficient to cover current liabilities. Free cash flow is negative at -₹480.23 million, and operating cash flow is -₹2,530.87 million, signaling significant cash outflows from operations. Profitability is weak, with a net loss of ₹446.00 million and an operating loss of ₹129.99 million. Return on equity is 21.28%, but this is misleading due to negative equity, and return on assets is -14.13%, below the typical performance of the Food Processing industry. Gross profit of ₹544.79 million is insufficient to cover operating expenses, contributing to the operating loss. The company operates in two segments: Sugar and Distillery. Revenue concentration is not disclosed by segment, but the sugar unit (Upper Doab Sugar Mills) and distillery unit (Shamli Distillery and Chemical Works) are both located in Uttar Pradesh, indicating geographic concentration risk. No international revenue is reported, and the company does not disclose any diversification into new markets or products beyond its core offerings. Growth trajectory is negative, with no disclosed revenue growth in the latest period. The company reported revenue of ₹2,683.41 million, but no prior period data is provided to assess year-over-year performance. Outlook for the current and next fiscal years is not quantified, but the negative operating and net income suggest ongoing operational challenges. Risk factors include high leverage, negative equity, and poor liquidity. The company has long-term debt of ₹3,308.83 million and no disclosed dilution sources, though dilution risk is assessed as low. Adjustments to valuations are not specified, but the negative net cash position is a key flag. Recent events include the launch of a hand sanitizer product, Clean Well Hand Sanitizer, which is a new revenue stream but not yet material to the company’s financials. No recent filings or transcripts are provided to assess management commentary or strategic shifts.